592
M. Abid et al. / Journal of Fluorine Chemistry 128 (2007) 587–594
4.3.4. 4-Methyl-N-[2,2,2-trifluoro-1-
4.3.10. N-[2,2,2-Trifluoro-1-phenylethylidene]naphth-2-yl-
amine (Table 2, Entry-10)
phenylethylidene]aniline (Table 1, Entry-4)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.20 (m, 5H),
6.98 (t, J = 3 Hz, 2H), 6.45 (t, J = 7.6 Hz, 2H), 2.25 (s, 3H).
13C NMR (100.53 MHz, CDCl3), d (ppm) 130.9, 130.2, 129.2,
128.2, 128.0, 126.1, 125.5, 118.9, 118.0, 91.3, 19.1, 19F NMR
(376.19 MHz, CDCl3, CFCl3-Ref), d (ppm) À70.0 (s, 3F).
MS-C15H12F3N (263), m/z (%): 263 (M+, 40), 194 (100), 91
(30).
1H NMR (399.81 MHz, CDCl3), d (ppm) 8.07 (dd, J = 7.6,
0.8 Hz, 2H), 7.67 (m, 5H), 7.41 (m, 3H), 6.87 (dd, J = 2.0,
8.4 Hz, 2H); 13C NMR (100.53 MHz, CDCl3), d (ppm) 144.8,
135.7, 133.7, 131.4, 130.5, 130.3, 130.2, 130.1, 129.3, 128.9,
128.8, 128.0, 127.9, 126.7, 125.7, 120.6, 118.4; 19F NMR
(376.19 MHz, CDCl3, CFCl3-Ref), d (ppm) À70.2 (s, 3F). MS-
C18H12F3N (299), m/z (%): 299 (M+, 50), 230 (100), 127 (95).
4.3.11. N-[1-Benzyl-2,2,2-trifluoroethylidene]-1-
4.3.5. 4-Methoxy-N-[2,2,2-trifluoro-1-
phenylethylamine (Table 3, Entry-1)
phenylethylidene]aniline (Table 2, Entry-5)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.27 (m, 10H),
5.28 (s, 2H), 4.83 (q, J = 6.4 Hz, 1H), 1.41 (d, J = 6.4 Hz, 3H);
13C NMR (100.53 MHz, CDCl3), d (ppm) 129.1, 128.7, 128.4,
127.4, 127.2, 126.6, 60.4, 33.3, 24.6; 19F NMR (376.19 MHz,
CDCl3, CFCl3-Ref), d (ppm) À72.6 (s, 3F). MS-C17H16F3N
(291), m/z (%): 291 (M+, 10), 187 (25), 105 (100), 77 (10).
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.29 (m, 5H),
7.22 (m, 2H), 6.71 (m, 2H), 3.72 (s, 3H); 13C NMR
(100.53 MHz, CDCl3), d (ppm) 157.9, 139.8, 130.9, 130.2,
128.9, 128.7, 123.5, 114.1, 55.8; 19F NMR (376.19 MHz,
CDCl3, CFCl3-Ref), d (ppm) À70.4 (s, 3F). MS-C15H12F3NO
(279), m/z (%): 279 (M+, 30), 210 (100), 195 (15), 167 (15),
105 (10), 77 (20).
4.3.12. N-[1-Benzyl-2,2,2-trifluoroethylidene]-2-
methylaniline (Table 3, Entry-2)
4.3.6. 3-(Trifluoromethyl)-N-[2,2,2-trifluoro-1-
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.18 (m, 9H), 2.27
(s, 2H), 1.24 (s, 3H); 13C NMR (100.53 MHz, CDCl3), d (ppm)
135.1, 133.5, 130.5, 129.6, 128.8, 128.4, 126.8, 120.7, 114.7,
59.8, 17.8; 19F NMR (376.19 MHz, CDCl3, CFCl3-Ref), d
(ppm) À70.5 (s, 3F). MS-C16H14F3N (277), m/z (%): 277 (M+,
75), 262 (10), 208 (40), 186 (100), 166 (30), 91 (60).
phenylethylidene]aniline (Table 2, Entry-6)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.30 (m, 5H), 7.02
(s, 1H), 6.86 (m, 2H); 13C NMR (100.53 MHz, CDCl3), d (ppm)
147.7, 131.4, 130.8, 129.6, 129.5, 129.3, 128.9, 128.7, 123.8,
122.2, 122.0, 118.0; 19F NMR (376.19 MHz, CDCl3, CFCl3-
Ref), d (ppm) À63.4 (s, 3F), À70.62 (s, 3F). MS-C15H8F6N
(317), m/z (%): 317 (M+, 20), 248 (100), 145 (40).
4.3.13. 1-Phenyl-N-[2,2,2-trifluoro-1-(1H-pyrrol-2-
yl)ethylidene]ethylamine (Table 3, Entry-3)
4.3.7. 4-Chloro-N-[2,2,2-trifluoro-1-
1H NMR (399.81 MHz, CDCl3), d (ppm) 8.40 (s, 1H), 7.34
(m, 5H), 6.91 (m, 1H), 6.61 (m, 1H), 6.29 (m, 1H), 5.01 (q,
J = 6.4 Hz, 1H), 2.15 (d, J = 6.4 Hz, 3H); 13C NMR
(100.53 MHz, CDCl3), d (ppm) 129.1, 128.7, 127.4, 127.3,
126.6, 126.2, 122.5, 121.7, 115.9, 110.1, 60.1, 24.9; 19F NMR
(376.19 MHz, CDCl3, CFCl3-Ref), d (ppm) À69.4 (s, 3F). MS-
C14H13F3N2 (266), m/z (%): 266 (M+, 10), 251 (15), 105 (100),
77 (20).
phenylethylidene]aniline (Table 2, Entry-7)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.35 (m, 5H), 7.00
(m, 2H), 6.68 (m, 2H). 13C NMR (100.53 MHz, CDCl3), d
(ppm) 130.7, 129.8, 129.2, 128.8, 128.4, 128.3, 122.2; 19F
NMR (376.19 MHz, CDCl3, CFCl3-Ref); d (ppm) À70.0 (s,
3F). MS-C14H9F3ClN (283), m/z (%): 283 (M+, 30), 214 (100),
111 (30), 75 (25).
4.3.8. 4-Fluoro-N-[2,2,2-trifluoro-1-
4.3.14. 2-Methyl-N-[2,2,2-trifluoro-1-(1H-pyrrol-2-
yl)ethylidene]aniline (Table 3, Entry-4)
phenylethylidene]aniline (Table 2, Entry-8)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.35 (m, 5H), 6.91
(m, 2H), 6.65 (m, 2H). 13C NMR (100.53 MHz, CDCl3), d
(ppm) 130.5, 128.9, 128.7, 122.8, 122.8, 119.1, 116.3, 115.8,
115.7, 19F NMR (376.19 MHz, CDCl3, CFCl3-Ref), d (ppm)
À70.6 (s, 3F). MS-C14H9F4N (267), m/z (%): 267 (M+, 25), 198
(100), 95 (40), 75 (15).
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.91 (s, 1H), 7.26
(m, 2H), 7.11 (t, J = 7.6 Hz, 2H), 6.78 (t, J = 8 Hz, 1H), 6.70 (q,
J = 1.2 Hz, 1H), 6.17 (quin, J = 2.4 Hz, 1H), 2.05 (s, 3H); 13
C
NMR (100.53 MHz, CDCl3), d (ppm) 131.7, 127.7, 126.2,
125.0, 124.4, 117.3, 110.2, 29.8; 19F NMR (376.19 MHz,
CDCl3, CFCl3-Ref), d (ppm) À67.6 (s, 3F). MS-C13H11F3N2
(252), m/z (%): 252 (M+, 30), 237 (100), 183 (50), 91 (60), 65
(45).
4.3.9. 1-Phenyl-N-[2,2,2-trifluoro-1-
phenylethylidene]ethylamine (Table 2, Entry-9)
1
Ref. [7(d)], H NMR (399.81 MHz, CDCl3), d (ppm) 7.46
4.3.15. 1-Phenyl-N-[2,2,2-trifluoro-1-(2-
(m, 5H), 7.25 (m, 5H), 4.53 (q, J = 6.4 Hz, 1H), 1.43 (dd,
J = 6.4 Hz, 3H, CH3); 13C NMR (100.53 MHz, CDCl3), d
(ppm) 143.7, 130.5, 130.0, 128.7, 128.6, 127.6, 127.2, 126.4,
51.9, 24.5; 19F NMR (376.19 MHz, CDCl3, CFCl3-Ref), d
(ppm) À71.5 (s, 3F). MS-C16H14F3N (277), m/z (%): 277 (M+,
10), 193 (5), 105 (100), 77 (20).
thiophenyl)ethylidene]ethylamine (Table 3, Entry-5)
1H NMR (399.81 MHz, CDCl3), d (ppm) 7.55 (m, 2H), 7.34
(m, 5H), 7.18 (m, 1H), 7.11 (m, 1H), 4.90 (q, J = 6.8 Hz, 1H),
1.55 (d, J = 6.8 Hz, 3H); 13C NMR (100.53 MHz, CDCl3), d
(ppm) 144.1, 136.2, 132.1, 129.5, 128.9, 127.2, 126.5, 121.1,
61.1, 24.5; 19F NMR (376.19 MHz, CDCl3, CFCl3-Ref), d